222 related articles for article (PubMed ID: 9358152)
1. The ETS family member ERM contains an alpha-helical acidic activation domain that contacts TAFII60.
Defossez PA; Baert JL; Monnot M; de Launoit Y
Nucleic Acids Res; 1997 Nov; 25(22):4455-63. PubMed ID: 9358152
[TBL] [Abstract][Full Text] [Related]
2. The AD1 transactivation domain of E2A contains a highly conserved helix which is required for its activity in both Saccharomyces cerevisiae and mammalian cells.
Massari ME; Jennings PA; Murre C
Mol Cell Biol; 1996 Jan; 16(1):121-9. PubMed ID: 8524288
[TBL] [Abstract][Full Text] [Related]
3. p53 transcriptional activation mediated by coactivators TAFII40 and TAFII60.
Thut CJ; Chen JL; Klemm R; Tjian R
Science; 1995 Jan; 267(5194):100-4. PubMed ID: 7809597
[TBL] [Abstract][Full Text] [Related]
4. Two functionally distinct domains responsible for transactivation by the Ets family member ERM.
Laget MP; Defossez PA; Albagli O; Baert JL; Dewitte F; Stehelin D; de Launoit Y
Oncogene; 1996 Mar; 12(6):1325-36. PubMed ID: 8649835
[TBL] [Abstract][Full Text] [Related]
5. ERM transactivation is up-regulated by the repression of DNA binding after the PKA phosphorylation of a consensus site at the edge of the ETS domain.
Baert JL; Beaudoin C; Coutte L; de Launoit Y
J Biol Chem; 2002 Jan; 277(2):1002-12. PubMed ID: 11682477
[TBL] [Abstract][Full Text] [Related]
6. Structural and functional properties of the N transcriptional activation domain of thyroid transcription factor-1: similarities with the acidic activation domains.
Tell G; Perrone L; Fabbro D; Pellizzari L; Pucillo C; De Felice M; Acquaviva R; Formisano S; Damante G
Biochem J; 1998 Jan; 329 ( Pt 2)(Pt 2):395-403. PubMed ID: 9425125
[TBL] [Abstract][Full Text] [Related]
7. Exon 4-encoded acidic domain in the epithelium-restricted Ets factor, ESX, confers potent transactivating capacity and binds to TATA-binding protein (TBP).
Chang CH; Scott GK; Baldwin MA; Benz CC
Oncogene; 1999 Jun; 18(25):3682-95. PubMed ID: 10391676
[TBL] [Abstract][Full Text] [Related]
8. Identification of highly conserved amino-terminal segments of dTAFII230 and yTAFII145 that are functionally interchangeable for inhibiting TBP-DNA interactions in vitro and in promoting yeast cell growth in vivo.
Kotani T; Miyake T; Tsukihashi Y; Hinnebusch AG; Nakatani Y; Kawaichi M; Kokubo T
J Biol Chem; 1998 Nov; 273(48):32254-64. PubMed ID: 9822704
[TBL] [Abstract][Full Text] [Related]
9. Region of yeast TAF 130 required for TFIID to associate with promoters.
Mencía M; Struhl K
Mol Cell Biol; 2001 Feb; 21(4):1145-54. PubMed ID: 11158301
[TBL] [Abstract][Full Text] [Related]
10. Modular organization of the E2F1 activation domain and its interaction with general transcription factors TBP and TFIIH.
Pearson A; Greenblatt J
Oncogene; 1997 Nov; 15(22):2643-58. PubMed ID: 9400991
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the human and mouse ETV1/ER81 transcription factor genes: role of the two alternatively spliced isoforms in the human.
Coutte L; Monté D; Imai K; Pouilly L; Dewitte F; Vidaud M; Adamski J; Baert JL; de Launoit Y
Oncogene; 1999 Nov; 18(46):6278-86. PubMed ID: 10597226
[TBL] [Abstract][Full Text] [Related]
12. An inhibitor domain in Sp3 regulates its glutamine-rich activation domains.
Dennig J; Beato M; Suske G
EMBO J; 1996 Oct; 15(20):5659-67. PubMed ID: 8896459
[TBL] [Abstract][Full Text] [Related]
13. Evolutionary conservation of human TATA-binding-polypeptide-associated factors TAFII31 and TAFII80 and interactions of TAFII80 with other TAFs and with general transcription factors.
Hisatake K; Ohta T; Takada R; Guermah M; Horikoshi M; Nakatani Y; Roeder RG
Proc Natl Acad Sci U S A; 1995 Aug; 92(18):8195-9. PubMed ID: 7667268
[TBL] [Abstract][Full Text] [Related]
14. Functional interaction of the c-Myc transactivation domain with the TATA binding protein: evidence for an induced fit model of transactivation domain folding.
McEwan IJ; Dahlman-Wright K; Ford J; Wright AP
Biochemistry; 1996 Jul; 35(29):9584-93. PubMed ID: 8755740
[TBL] [Abstract][Full Text] [Related]
15. Expression, purification, and structural prediction of the Ets transcription factor ERM.
Mauen S; Huvent I; Raussens V; Demonte D; Baert JL; Tricot C; Ruysschaert JM; Van Lint C; Moguilevsky N; de Launoit Y
Biochim Biophys Acta; 2006 Aug; 1760(8):1192-201. PubMed ID: 16730909
[TBL] [Abstract][Full Text] [Related]
16. ADR1-mediated transcriptional activation requires the presence of an intact TFIID complex.
Komarnitsky PB; Klebanow ER; Weil PA; Denis CL
Mol Cell Biol; 1998 Oct; 18(10):5861-7. PubMed ID: 9742103
[TBL] [Abstract][Full Text] [Related]
17. Incorporation of Drosophila TAF110 into the yeast TFIID complex does not permit the Sp1 glutamine-rich activation domain to function in vivo.
Keaveney M; Struhl K
Genes Cells; 1999 Apr; 4(4):197-203. PubMed ID: 10336691
[TBL] [Abstract][Full Text] [Related]
18. Ras signaling and transcriptional synergy at a flexible Ets-1/Pit-1 composite DNA element is defined by the assembly of selective activation domains.
Duval DL; Jean A; Gutierrez-Hartmann A
J Biol Chem; 2003 Oct; 278(41):39684-96. PubMed ID: 12902343
[TBL] [Abstract][Full Text] [Related]
19. Distinct domains of hTAFII100 are required for functional interaction with transcription factor TFIIF beta (RAP30) and incorporation into the TFIID complex.
Dubrovskaya V; Lavigne AC; Davidson I; Acker J; Staub A; Tora L
EMBO J; 1996 Jul; 15(14):3702-12. PubMed ID: 8758937
[TBL] [Abstract][Full Text] [Related]
20. Molecular cloning and characterization of human ERM, a new member of the Ets family closely related to mouse PEA3 and ER81 transcription factors.
Monté D; Baert JL; Defossez PA; de Launoit Y; Stéhelin D
Oncogene; 1994 May; 9(5):1397-406. PubMed ID: 8152800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
